MICAL2 Implies Immunosuppressive Features and Acts as an Independent and Adverse Prognostic Biomarker in Pancreatic Cancer

Researchers showed that microtubule associated monooxygenase, calponin and LIM domain containing 2 (MICAL2) was highly expressed in pancreatic cancer tissue and exhibited potential diagnostic capability. High expression of MICAL2 was also associated with poor prognosis and acted as an independent prognostic factor.